Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-05-23

Clinical Trial Update: Renal Denervation in Treatment Resistant Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating renal denervation for treatment-resistant hypertension was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Henrik Vase | Conditions: Hypertension | Phase 3 | Status: TERMINATED